Canntab Therapeutics Limited Stock Today
| CTABF Stock | USD 0.0001 0.00 0.00% |
Performance0 of 100
| Odds Of DistressLess than 35
|
Canntab Therapeutics is trading at 1.0E-4 as of the 27th of November 2024. This is a No Change since the beginning of the trading day. The stock's lowest day price was 1.0E-4. Canntab Therapeutics has about a 35 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. Equity ratings for Canntab Therapeutics Limited are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 28th of October 2024 and ending today, the 27th of November 2024. Click here to learn more.
Canntab Therapeutics Limited, a phytopharmaceutical company, engages in the research and development of advanced pharmaceutical grade formulations of cannabinoids in Canada. Canntab Therapeutics Limited is headquartered in Markham, Canada. Canntab Therapeutics is traded on OTC Exchange in the United States.. The company has 38.91 M outstanding shares. More on Canntab Therapeutics Limited
Moving against Canntab Pink Sheet
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Canntab Pink Sheet Highlights
| CoFounder, CEO | Richard Goldstein |
| Business Concentration | Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) |
Canntab Therapeutics Limited [CTABF] is a Pink Sheet which is traded between brokers over the counter. The company currently falls under 'Nano-Cap' category with a current market capitalization of 774.29 K. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Canntab Therapeutics's market, we take the total number of its shares issued and multiply it by Canntab Therapeutics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Canntab Therapeutics classifies itself under Healthcare sector and is part of Drug Manufacturers—Specialty & Generic industry. The entity has 38.91 M outstanding shares.
Canntab Therapeutics Limited has accumulated about 691.11 K in cash with (2.85 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.02, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Canntab Therapeutics Probability Of Bankruptcy
Ownership AllocationCanntab Therapeutics holds a total of 38.91 Million outstanding shares. Canntab Therapeutics Limited shows 15.08 percent of its outstanding shares held by insiders and 0.0 percent owned by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Canntab Ownership Details
Canntab Therapeutics Risk Profiles
| Mean Deviation | 2.84 | |||
| Standard Deviation | 11.69 | |||
| Variance | 136.74 | |||
| Risk Adjusted Performance | (0.08) |
Canntab Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Canntab Therapeutics without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Bond Analysis Now
Bond AnalysisEvaluate and analyze corporate bonds as a potential investment for your portfolios. |
| All Next | Launch Module |
Other Information on Investing in Canntab Pink Sheet
Canntab Therapeutics financial ratios help investors to determine whether Canntab Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Canntab with respect to the benefits of owning Canntab Therapeutics security.